Cohort Profile: Seek and Treat for the Optimal Prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC)

Overview

Journal Int J Epidemiol

Specialty Public Health

Date 2014 Apr 4

PMID 24695113

Citations 45

Authors

Kate Heath

Hasina Samji

Bohdan Nosyk

Guillaume Colley

Mark Gilbert

Robert S Hogg

Julio Sg Montaner

Affiliations

Soon will be listed here.

Abstract

The Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) cohort is a census of all identified HIV-positive individuals in the province of British Columbia. It was formed through the linkage of nine provincial treatment, surveillance and administrative databases. This open cohort allows for bidirectional analyses from 1996 onward and is refreshed annually. Extensive data collection for cohort members includes demographic information, detailed clinical and laboratory data, complete prescription drug use including antiretroviral agents, and information on health service utilization encompassing inpatient and outpatient care, addictions treatment and palliative care. This cohort provides an unprecedented opportunity to evaluate, over an extended time period, patterns and determinants of key outcomes including engagement in the cascade of HIV care from diagnosis to treatment to viral suppression as well as monitoring trends in medical costs, health outcomes and other key healthcare delivery indicators at a population level with wide-ranging, high-quality data. The overall purpose of these activities is to enable the development and implementation of strategically targeted interventions to improve access to testing, care and treatment for all HIV-positive individuals living in British Columbia.

Citing Articles

Incidence and contributing factors of dementia among people living with HIV in British Columbia, Canada, from 2002 to 2016: a retrospective cohort study.

Shayegi-Nik S, Honer W, Vila-Rodriguez F, Nanditha N, Patterson T, Guillemi S BMJ Public Health. 2025; 2(1):e000627.

PMID: 40018107 PMC: 11816979. DOI: 10.1136/bmjph-2023-000627.

Differences in elementary-age children's accelerometer - measured physical activity between school and summer: three-year findings from the What's UP (Undermining Prevention) with summer observational cohort study.

Beets M, Burkart S, Pfledderer C, Adams E, Weaver R, Armstrong B Int J Behav Nutr Phys Act. 2024; 21(1):86.

PMID: 39107808 PMC: 11304806. DOI: 10.1186/s12966-024-01637-z.

Prevalence and Correlates of Heavy Alcohol use among People Living with HIV who use Unregulated Drugs in Vancouver, Canada.

Hui J, Reddon H, Fairbairn N, Choi J, Milloy M, Socias M AIDS Behav. 2024; 28(7):2427-2437.

PMID: 38662276 DOI: 10.1007/s10461-024-04341-y.

COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis.

Puyat J, Wilton J, Fowokan A, Janjua N, Wong J, Grennan T J Int AIDS Soc. 2023; 26(10):e26178.

PMID: 37885156 PMC: 10603274. DOI: 10.1002/jia2.26178.

Identification of people with low prevalence diseases in administrative healthcare records: A case study of HIV in British Columbia, Canada.

Emerson S, McLinden T, Sereda P, Lima V, Hogg R, Kooij K PLoS One. 2023; 18(8):e0290777.

PMID: 37651428 PMC: 10470893. DOI: 10.1371/journal.pone.0290777.

References

Hogg R, Heath K, Lima V, Nosyk B, Kanters S, Wood E . Disparities in the burden of HIV/AIDS in Canada. PLoS One. 2012; 7(11):e47260. PMC: 3507870. DOI: 10.1371/journal.pone.0047260. View

Wood E, Kerr T, Marshall B, Li K, Zhang R, Hogg R . Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009; 338:b1649. PMC: 2675696. DOI: 10.1136/bmj.b1649. View

Montaner J, Lima V, Barrios R, Yip B, Wood E, Kerr T . Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010; 376(9740):532-9. PMC: 2996043. DOI: 10.1016/S0140-6736(10)60936-1. View

Nosyk B, Colley G, Yip B, Chan K, Heath K, Lima V . Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, Canada. PLoS One. 2013; 8(1):e54416. PMC: 3557280. DOI: 10.1371/journal.pone.0054416. View

Lima V, Hogg R, Montaner J . Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada. PLoS One. 2010; 5(6):e10991. PMC: 2881871. DOI: 10.1371/journal.pone.0010991. View

Brown J, Shesser R, Simon G, Bahn M, Czarnogorski M, Kuo I . Routine HIV screening in the emergency department using the new US Centers for Disease Control and Prevention Guidelines: results from a high-prevalence area. J Acquir Immune Defic Syndr. 2007; 46(4):395-401. DOI: 10.1097/qai.0b013e3181582d82. View

Czarnogorski M, Brown J, Lee V, Oben J, Kuo I, Stern R . The Prevalence of Undiagnosed HIV Infection in Those Who Decline HIV Screening in an Urban Emergency Department. AIDS Res Treat. 2011; 2011:879065. PMC: 3124124. DOI: 10.1155/2011/879065. View

Marshall B, Milloy M, Wood E, Montaner J, Kerr T . Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011; 377(9775):1429-37. DOI: 10.1016/S0140-6736(10)62353-7. View

Thompson M, Aberg J, Cahn P, Montaner J, Rizzardini G, Telenti A . Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010; 304(3):321-33. DOI: 10.1001/jama.2010.1004. View

10.

Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505. PMC: 3200068. DOI: 10.1056/NEJMoa1105243. View

11.

Nosyk B, Montaner J, Colley G, Lima V, Chan K, Heath K . The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study. Lancet Infect Dis. 2013; 14(1):40-49. PMC: 4017913. DOI: 10.1016/S1473-3099(13)70254-8. View

12.

Joy R, Druyts E, Brandson E, Lima V, Rustad C, Zhang W . Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008; 47(4):500-5. DOI: 10.1097/QAI.0b013e3181648dfd. View

13.

Yang Q, Boulos D, Yan P, Zhang F, Remis R, Schanzer D . Estimates of the number of prevalent and incident human immunodeficiency virus (HIV) infections in Canada, 2008. Can J Public Health. 2011; 101(6):486-90. PMC: 6974128. View

14.

Montaner J, Hogg R, Wood E, Kerr T, Tyndall M, Levy A . The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006; 368(9534):531-6. DOI: 10.1016/S0140-6736(06)69162-9. View

15.

Gardner E, McLees M, Steiner J, Del Rio C, Burman W . The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011; 52(6):793-800. PMC: 3106261. DOI: 10.1093/cid/ciq243. View

16.

Antoniou T, Zagorski B, Loutfy M, Strike C, Glazier R . Validation of case-finding algorithms derived from administrative data for identifying adults living with human immunodeficiency virus infection. PLoS One. 2011; 6(6):e21748. PMC: 3128093. DOI: 10.1371/journal.pone.0021748. View